Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter II Section 1.7: Difference between revisions

From GxPlex

Jump to: navigation, search
gxplex>GxPlexBot
Import from GxPlex Excel
m 1 revision imported
 
(6 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{#set:
{{ReferenceData
|HasDocument=Document:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023
|has_document=Document:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023
|RefScope=MD
|module=1
|RefDocPart=Annex XV
|unit=1.5.4
|scope=MD
|doc_part=Annex XV
Chapter II
Chapter II
Section 1.7
Section 1.7
|RefLanguage=EN
|language=EN
|RefTagsEN=
|entry_by=Florian Adragna
|RefTagsOriginal=
|contributors=
|RefTagsFR=
|tags=TAG-00343-Doc-ten ++ TAG-00201-Cli-eSt ++ TAG-00202-Inv-Pro ++ TAG-00017-Spo-die
}}
|tags_display=[[Glossary:TAG-00343-Doc-ten|Documentation]], [[Glossary:TAG-00201-Cli-eSt|Clinical investigation]], [[Glossary:TAG-00202-Inv-Pro|Investigational device]], [[Glossary:TAG-00017-Spo-die|Sponsor]]
 
|comment=Documentation required for clinical investigation application (device)
{{:Document:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023}}
|content=DOCUMENTATION REGARDING THE APPLICATION FOR CLINICAL INVESTIGATION
 
{| class="gplx-infobox"
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Scope
| MD
|-
! Document part
| Annex XV
Chapter II
Section 1.7
|-
! Language
| EN
|-
! Original entry by
| Florian Adragna
|-
! Contributors
|
|-
! Tags (EN)
|
|-
! Tags (original language)
|
|-
! Tags (FR)
|  
|-
! Comment
| Documentation required for clinical investigation application (device)
|}
 
== Content ==
DOCUMENTATION REGARDING THE APPLICATION FOR CLINICAL INVESTIGATION


For investigational devices covered by Article 62, the sponsor shall draw up and submit the application in accordance with Article 70 accompanied by the following documents:
For investigational devices covered by Article 62, the sponsor shall draw up and submit the application in accordance with Article 70 accompanied by the following documents:
Line 58: Line 23:


1.7. if the application is submitted in parallel with an application for a clinical trial in accordance with Regulation (EU) No 536/2014, reference to the official registration number of the clinical trial;
1.7. if the application is submitted in parallel with an application for a clinical trial in accordance with Regulation (EU) No 536/2014, reference to the official registration number of the clinical trial;
}}

Latest revision as of 13:49, 16 July 2026



Document information
Reference EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023
Validity area EU
Scope(s) MD
Document name Regulation (EU) 2017/745 - Medical Device Regulation
Version / Revision 20-Mar-2023
Status Current
Document type Legal act
Language(s) EN
Description REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC
Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 1 — Unit 1.5.4
Scope MD
Document part Annex XV

Chapter II Section 1.7

Language EN
Original entry by Florian Adragna
Contributors
Tags Documentation, Clinical investigation, Investigational device, Sponsor

Content

DOCUMENTATION REGARDING THE APPLICATION FOR CLINICAL INVESTIGATION

For investigational devices covered by Article 62, the sponsor shall draw up and submit the application in accordance with Article 70 accompanied by the following documents:

1. Application form

The application form shall be duly filled in, containing information regarding: [...]

1.7. if the application is submitted in parallel with an application for a clinical trial in accordance with Regulation (EU) No 536/2014, reference to the official registration number of the clinical trial;